What is the recommended protocol for switching from Prozac (fluoxetine) to Luvox (fluvoxamine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Switching from Prozac (Fluoxetine) to Luvox (Fluvoxamine)

Due to fluoxetine's exceptionally long half-life (4-6 days) and its active metabolite norfluoxetine (4-16 days), you must allow at least 5 weeks of washout after stopping Prozac before starting Luvox to avoid drug interactions and serotonin toxicity. 1

Recommended Switching Protocol

Step 1: Discontinue Fluoxetine Gradually

  • Taper fluoxetine gradually rather than stopping abruptly to minimize withdrawal symptoms 2
  • The tapering schedule depends on current dose and duration of treatment
  • Monitor closely for discontinuation symptoms (anxiety, irritability, mood changes, dizziness)

Step 2: Washout Period

This is the critical step that distinguishes fluoxetine from other antidepressants:

  • Allow a minimum 5-week washout period after the last fluoxetine dose before initiating fluvoxamine 1
  • This extended washout is necessary because fluoxetine and its active metabolite persist in the system far longer than other SSRIs
  • Both fluoxetine and fluvoxamine are potent CYP2D6 inhibitors, creating potential for significant drug interactions if overlapped 3

Step 3: Initiate Fluvoxamine

After the 5-week washout:

  • Start fluvoxamine at 50 mg once daily at bedtime in adults 4
  • Increase in 50 mg increments every 4-7 days as tolerated
  • Target dose range: 100-300 mg/day (doses >100 mg should be divided twice daily, with larger dose at bedtime) 4

Key Clinical Considerations

Why Direct Cross-Taper is NOT Safe Here

Unlike switches between most SSRIs where direct cross-tapering may be possible 2, the fluoxetine-to-fluvoxamine switch requires conservative management because:

  • Both drugs significantly inhibit CYP2D6 metabolism 3
  • Fluoxetine's extraordinarily long elimination creates risk of serotonin syndrome if overlapped
  • The FDA label explicitly mandates this 5-week interval 1

Monitoring During the Washout Period

This 5-week gap presents clinical challenges:

  • Patients remain untreated during washout, risking depressive relapse 2
  • Monitor weekly for worsening depression, suicidal ideation, or severe withdrawal symptoms 5
  • If severe deterioration occurs, consider whether the switch is appropriate or if bridging strategies are needed (though this requires expert consultation)

Dose Equivalency Context

Based on flexible-dose trial data, fluoxetine 40 mg/day is approximately equivalent to fluvoxamine 143 mg/day 6. Use this as a rough guide for target dosing, though individual titration based on response is essential.

Special Populations

  • Elderly or hepatically impaired patients: Start fluvoxamine at lower doses (25 mg) and titrate more slowly due to decreased clearance 4
  • Pediatric patients (8-17 years): Start at 25 mg daily at bedtime 4

Common Pitfalls to Avoid

  1. Starting fluvoxamine too early: The 5-week washout is non-negotiable—shorter intervals risk serotonin syndrome
  2. Abrupt fluoxetine discontinuation: Always taper to minimize withdrawal, even though washout is required
  3. Inadequate monitoring during washout: Weekly contact is essential during this vulnerable period
  4. Forgetting divided dosing: Fluvoxamine doses >100 mg/day require BID dosing for tolerability 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.